157 related articles for article (PubMed ID: 28069655)
1. Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
Kumar P; Kaushik A; Bell DT; Chauhan V; Xia F; Stevens RL; Lamichhane G
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069655
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Zhang D; Wang Y; Lu J; Pang Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
[TBL] [Abstract][Full Text] [Related]
3. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
Cohen KA; El-Hay T; Wyres KL; Weissbrod O; Munsamy V; Yanover C; Aharonov R; Shaham O; Conway TC; Goldschmidt Y; Bishai WR; Pym AS
EBioMedicine; 2016 Jul; 9():170-179. PubMed ID: 27333036
[TBL] [Abstract][Full Text] [Related]
5. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
Kurz SG; Wolff KA; Hazra S; Bethel CR; Hujer AM; Smith KM; Xu Y; Tremblay LW; Blanchard JS; Nguyen L; Bonomo RA
Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876
[TBL] [Abstract][Full Text] [Related]
6. Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Gonzalo X; Drobniewski F
J Antimicrob Chemother; 2013 Feb; 68(2):366-9. PubMed ID: 23070734
[TBL] [Abstract][Full Text] [Related]
7. [
Shi J; Zheng DW; Ma XG; Su RY; Zhu YK; Wang SH; Chang WJ; Sun GQ; Sun DY
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):797-805. PubMed ID: 37536990
[No Abstract] [Full Text] [Related]
8. Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.
Dubée V; Triboulet S; Mainardi JL; Ethève-Quelquejeu M; Gutmann L; Marie A; Dubost L; Hugonnet JE; Arthur M
Antimicrob Agents Chemother; 2012 Aug; 56(8):4189-95. PubMed ID: 22615283
[TBL] [Abstract][Full Text] [Related]
9. Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.
Trigos AS; Goudey BW; Bedő J; Conway TC; Faux NG; Wyres KL
mSphere; 2021 Jun; 6(3):e0024521. PubMed ID: 34047652
[TBL] [Abstract][Full Text] [Related]
10. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Dinçer I; Ergin A; Kocagöz T
Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
[TBL] [Abstract][Full Text] [Related]
11. Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.
Viswanathan G; Yadav S; Raghunand TR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438925
[TBL] [Abstract][Full Text] [Related]
12. Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of
Olivença F; Pires D; Silveiro C; Gama B; Holtreman F; Anes E; Catalão MJ
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0158623. PubMed ID: 38411952
[TBL] [Abstract][Full Text] [Related]
13. In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
Cordillot M; Dubée V; Triboulet S; Dubost L; Marie A; Hugonnet JE; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2013 Dec; 57(12):5940-5. PubMed ID: 24041897
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
Wivagg CN; Bhattacharyya RP; Hung DT
J Antibiot (Tokyo); 2014 Sep; 67(9):645-54. PubMed ID: 25052484
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
Soroka D; Li de la Sierra-Gallay I; Dubée V; Triboulet S; van Tilbeurgh H; Compain F; Ballell L; Barros D; Mainardi JL; Hugonnet JE; Arthur M
Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Sharma AK; Vats P
Indian J Tuberc; 2019 Jan; 66(1):92-98. PubMed ID: 30797291
[TBL] [Abstract][Full Text] [Related]
18. Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing.
Olivença F; Nunes A; Macedo R; Pires D; Silveiro C; Anes E; Miragaia M; Gomes JP; Catalão MJ
Microbiol Spectr; 2022 Aug; 10(4):e0067422. PubMed ID: 35695524
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
Danilchanka O; Mailaender C; Niederweis M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2503-11. PubMed ID: 18458127
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.
Egesborg P; Carlettini H; Volpato JP; Doucet N
Protein Sci; 2015 Apr; 24(4):534-44. PubMed ID: 25492589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]